Nuvaprin and hemorrhoids are rarely words that go together, but this supplement may actually help to relieve the painful and uncomfortable symptoms that hemorrhoids can bring. A hemorrhoid is actually a blood vessel in the anal area that becomes swollen and can become painful. Nuvaprin is a supplement that has been shown to be effective in maintaining good vascular health by supporting vascular tissue.
While this supplement is touted as being effective in reducing varicose veins in the legs, it would stand to reason that it would work with these types of veins in other areas of the body as well. The reason that Nuvaprin can treat hemorrhoids is an ingredient that is found within it called diosmin.
What is Diosmin?
Diosmin is a flavonoid that can be extracted from plant matter, and has long been thought to contribute to vascular health. In addition to treating hemorrhoids with Nuvaprin, diosmin can also be used effectively for lymph edema and varicose veins.
Some studies have shown that diosmin can be quite effective in treating hemorrhoids when taken orally, either as a sole treatment plan, or in conjunction with another type of hemorrhoid treatment like rubber band ligation or surgery. It has been shown to support and enhance many aspect of vascular health, making it a good option in the treatment of numerous vascular diseases and disorders.
Studies show a Link between Nuvaprin and Hemorrhoids
There have been numerous studies that show a connection between the diosmin that is found in Nuvaprin and hemorrhoid treatment. Many of the patients that participated in the study found relief from their hemorrhoid symptoms within a matter of days.
Clinical studies also show that there does not seem to be any contraindications for using this substance during pregnancy, which is a time when hemorrhoids often occur. Many women participating in this study found significant relief from hemorrhoids in less than a week. The diosmin in Nuvaprin and hemorrhoids seem to have a conclusive and positive relationship indeed.
Diosmin 95, which is a combination of diosmin and hesperidin, was approved for consumer use by the FDA in 2005. This is the substance that is found in Nuvaprin HD, which can be found in vitamin stores as well as on the Internet.
While this medication is available by prescription in Europe as a means to treat varicose and spider veins, it is currently available in the United States without a prescription. If you are looking for relief from the uncomfortable symptoms of hemorrhoids, Nuvaprin HD might be the answer for you.
Open My Eyes That I May See
Three mid-sized health insurers that recently took steps to put troubles behind them are possible prey: Coventry Health Care Inc (CVH.N), Health Net Inc (HNT.N) and WellCare Health Plans Inc (WCG.N).
"To the extent that healthcare reform creates consolidation, you could start to see companies like Coventry and Health Net and WellCare beginning to attract a consolidation premium," Stifel Nicolaus analyst Thomas Carroll said.
Major acquisitions are doubtful while Congress debates healthcare reform this year, analysts say. Not only is there uncertainty over potential changes to the market, but striking a high-profile deal just as lawmakers question the amount of competition in the sector might seem politically foolish.
As reforms take shape, however, the desire to get bigger could manifest in deals later this year or next year.
"Reform creates a need for scale," said Bob Atlas, chief operating officer of Avalere Health, a research and strategic advisory firm.
"For commercial players to be able to scale up, to have strong geographic footprints, breath of products, breath of provider networks is going to be a positive -- that's what an acquirer would be looking for," Atlas said.
The weak economy also may be driving a need to acquire more size, said Dave Shove, an analyst with BMO Capital Markets, although he notes the rocky markets have created less investment income for the companies to use in deals.
"In normal circumstances, there is an ongoing drive to consolidate because it's a mature business and membership is difficult to come by," Shove said. "In this environment, with higher unemployment and virtually no membership gains, the drive is probably more pronounced."
Although they have recovered some in 2009, shares of health insurers have stumbled badly since early last year because of profit warnings and uncertainty over healthcare reform.
"If you do have the cash, there's probably the ability to be opportunistic," Shove said. "It's not quite like buying a house out of foreclosure, but certainly some of these stocks are cheap."
After years of managed care consolidation, large-scale mergers seem unlikely now, one healthcare investment banker said.
"There's really only four or five major national players, and there's not much room to consolidate those," said the banker, who declined to be named. "There may be opportunity for some small to mid-sized regionals, but not on a large scale."
Coventry and Health Net, with market values of about $3 billion and $2 billion respectively, both reported first-quarter results that signaled to analysts that they may have moved past operational problems from last year.
Maryland-based Coventry could bring an acquirer regional strength in the private market serving employers, as well as members in the Medicare and Medicaid government health plans.
Health Net, which is conducting a strategic review of its Arizona and Northeast operations, has a big California presence and a military health insurance business.
Both companies also recently shifted their management, as has WellCare. Just this week, WellCare said it agreed to pay $80 million to settle healthcare fraud allegations in a case that has left a cloud over the company since agents raided its Florida offices in 2007.
WellCare, with market value of about $900 million, operates only Medicare plans for seniors and Medicaid plans for low-income Americans, so it would attract buyers looking for added strength in those areas.
"I'm not sure any of the boards have an outright goal of selling the organizations, but clearly any thoughtful board would have that option on the table," Shove said.
Coventry declined to comment, but Chief Executive Allen Wise said last month on the company's quarterly conference call that management "understands the company is not for sale."
A WellCare spokeswoman said the company did not feel it was appropriate to discuss the takeout speculation. A Health Net spokeswoman said the company does not speculate about what might happen in the market.
Other health plans may be more preferable targets.
As reforms make Medicaid a potentially more enticing market, three publicly traded companies that specialize in the area -- Amerigroup Corp (AGP.N), Centene Corp (CNC.N) and Molina Healthcare Inc (MOH.N) -- may draw interest. Small privately held Medicare-focused plans also may see bids.
At the same time, potential buyers, such as Cigna Corp (CI.N), might be less inclined to part with cash until investor concerns over balance sheets dissipate.
Stifel's Carroll said potential targets will also want to see their valuations rise before selling.
"As we get more visibility on healthcare reform, and if that visibility suggests that scale will ultimately win, I think at that point we see a marked increase in consolidation," Carroll said. (Additional reporting by Jessica Hall in Philadelphia, editing by Gerald E. McCormick)
Both Ann Marier & Maury Klein are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.
Ann Marier has sinced written about articles on various topics from Sleep Disorders, Depression Cure and Mothers Day. Ann Marier has written many articles on different Her latest articles are about. Ann Marier's top article generates over 90500 views. to your Favourites.
Maury Klein has sinced written about articles on various topics from Credit Cards, Religion and Malware. Quoting and Saving on your health insurance has never been easier. . Maury Klein's top article generates over 1830000 views. to your Favourites.
Any Kind Of Work Your talent is your profession and for this you can work at home